One (case 10 with AML-MLL) died in remission of his medulloblastoma of septicemia during bone marrow transplant, and two were not in remission of their brain tumor (cases 16 and 27) and thus not eligible for bone marrow transplant. The gene discussed is KMT2A; the disease is brain neoplasm.